INNOCARE Releases Interim Report with H1 Net Loss of 30.09 Million Yuan

Deep News
2025/08/19

On August 19, INNOCARE released its interim report for the first half of 2025.

According to the announcement, the company recorded operating revenue of 731,434,172.32 yuan for the six-month period, representing a 74.26% year-over-year increase. The net profit attributable to shareholders of the listed company was -30,091,411.19 yuan.

The announcement also revealed changes among the top ten tradable shareholders, with Bank of China Limited - E Fund Healthcare Industry Hybrid Securities Investment Fund and China Construction Bank Corporation - Bosera Innovation Healthcare Theme Hybrid Securities Investment Fund being newly added as tradable shareholders.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10